Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10911041 | Lung Cancer | 2013 | 8 Pages |
Abstract
Gefitinib-treated EGFR-TKI-sensitive NSCLC cells showed a wide spectrum of chemo-refractoriness, suggesting that concomitantly combined EGFR-TKI-chemotherapy might not be a good treatment strategy for NSCLC harboring SEM.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Chun-Ming Tsai, Jen-Ting Chen, Chao-Hua Chiu, Chun-Liang Lai, Shih-Yin Hsiao, Kuo-Ting Chang,